Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 11,500.00
Ask: 12,270.00
Change: 0.00 (0.00%)
Spread: 770.00 (6.696%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: AstraZeneca CFO makes $1.5m sale, IHG chair buys in

Tue, 09th May 2023 14:28

(Sharecast News) - At the top of the list of FTSE 350 director sells on Tuesday was AstraZeneca, whose chief financial officer sold almost $1.5m worth of the company's American depositary shares.

The pharmaceuticals giant said Aradhana Sarin sold 19,470 of the shares on 5 May, at a price of $74.81 each.

That valued the transaction at a total of $1,456,550.70.

Two of AstraZeneca's American depositary shares are equivalent to one of its ordinary shares, the firm said in its disclosure.

On the buying side of things, the non-executive chair of InterContinental Hotels Group was also dealing in American depositary instruments, spending almost $0.35m.

The owner of brands including Holiday Inn said Deanna Oppenheimer acquired 5,000 of its American depositary receipts on the New York Stock Exchange on 8 May.

Oppenheimer paid $68.89 for each ADR, valuing the purchase at $344,450 in total.

At 1437 BST, shares in AstraZeneca were up 0.11% in London at 11,884p, while those in InterContinental Hotels Group were 0.6% firmer at 5,442p.

Reporting by Josh White for Sharecast.com.

DIRECTOR SELLS

Company: AstraZeneca

Name: Aradhana Sarin

Volume: 19,470

Price: $74.81

Value: $1,456,550.70

Company: London Stock Exchange Group

Name: York Holdings II

Volume: 9,048

Price: 8,359.77p

Value: £756,391.99

DIRECTOR BUYS

Company: InterContinental Hotels Group

Name: Deanna Oppenheimer

Volume: 5,000

Price: $68.89

Value: $344,450.00

Company: CRH

Name: Christina Verchere

Volume: 1,000

Price: 3,824.4p

Value: £38,244.00

Company: Videndum

Name: Andrea Rigamonti

Volume: 3,500

Price: 789.86p

Value: £27,645.07

Company: InterContinental Hotels Group

Name: Graham Allan

Volume: 300

Price: 5,418.36p

Value: £16,255.09

Company: Marshalls

Name: Martyn Coffey

Volume: 10,000

Price: 156p

Value: £15,600.00

Company: InterContinental Hotels Group

Name: Duriya Farooqui

Volume: 200

Price: $68.625

Value: $13,725.00

Company: InterContinental Hotels Group

Name: Daniela Barone Soares

Volume: 150

Price: 5,427.55p

Value: £8,141.33

Company: Marshalls

Name: Alison Lockwood

Volume: 3,763

Price: 164p

Value: £6,171.32

Company: Marshalls

Name: Amanda Bourne

Volume: 1,062

Price: 280p

Value: £2,973.60

Company: CMC Markets

Name: Euan William Marshall

Volume: 164

Price: 181.99p

Value: £298.46

Company: CMC Markets

Name: David John Fineberg

Volume: 164

Price: 181.99p

Value: £298.46

Company: Moneysupermarket.com Group

Name: Matthew Cresswell

Volume: 56

Price: 267.3p

Value: £149.69

Company: Moneysupermarket.com Group

Name: Peter Duffy

Volume: 56

Price: 267.3p

Value: £149.69

Company: Moneysupermarket.com Group

Name: Matthew Whittle

Volume: 38

Price: 267.3p

Value: £101.57

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.